Article | May 27, 2026

Achieving Manufacturing Milestones Through Systematic Tech Transfer

By Amit Jogi, Ph.D., Senior General Manager, Biopharmaceutical Operations

GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab

Technology transfer is a critical step in biologics manufacturing, bridging the gap between early development and large-scale production. It involves transferring process knowledge, analytical methods, and quality expectations from one site to another while maintaining product integrity and regulatory compliance.

However, this process is often complex and prone to challenges, including differences in equipment, incomplete data, scale-up limitations, and tight timelines. Poorly executed transfers can lead to production delays, quality issues, and increased costs, making a structured and reliable approach essential.

A systemic, risk-based methodology offers a solution by assessing process understanding, identifying potential gaps, and defining appropriate mitigation strategies before execution. By evaluating confidence levels in both process and analytical data, manufacturers can determine the most effective transfer pathway and ensure smooth scale-up.

This approach supports consistent performance, accelerates timelines, and helps achieve key manufacturing milestones with greater predictability and efficiency.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online